Sequential therapies for proliferative lupus nephritis [1] (multiple letters)

New England Journal of Medicine

Volumn 350, Issue 24, 2004, Pages 2518-2520

  Yee, Chee Seng ^a   Gordon, Caroline ^a   Gelber, Allan C ^b   Christopher Stine, Lisa ^b   Fine, Derek M ^b   Farhey, Yolanda ^c   Hess, Evelyn ^c   Contreras, Gabriel ^d   Lenz, Oliver ^d   Roth, David ^d  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CINCINNATI   (United States)

^d UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DNA ANTIBODY; DOUBLE STRANDED DNA; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; DRUG DERIVATIVE; MYCOPHENOLIC ACID;

ANTIBODY TITER; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LETTER; LUPUS ERYTHEMATOSUS; LUPUS ERYTHEMATOSUS NEPHRITIS; MORTALITY; NEPHRITIS; PRIORITY JOURNAL; PROGNOSIS; RISK; TREATMENT OUTCOME; ETHNOLOGY; HOSPITALIZATION; NOTE; RECURRENT DISEASE; COMPARATIVE STUDY; DRUG ADMINISTRATION; FOLLOW UP; STATISTICAL ANALYSIS; TIME; CLASSIFICATION; DRUG COMBINATION; FEMALE; MULTIVARIATE ANALYSIS; REMISSION;

AZATHIOPRINE; CYCLOPHOSPHAMIDE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUPUS NEPHRITIS; MYCOPHENOLIC ACID; PREDNISONE; RECURRENCE; SEVERITY OF ILLNESS INDEX; DATA INTERPRETATION, STATISTICAL; DRUG ADMINISTRATION SCHEDULE; FOLLOW-UP STUDIES; KIDNEY FAILURE, CHRONIC; TIME FACTORS; DRUG THERAPY, COMBINATION; FEMALE; MULTIVARIATE ANALYSIS; REMISSION INDUCTION; RISK;

EID: 2942565863     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200406103502416     Document Type: Letter

References (0)